ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$1.29 USD
+0.03 (2.38%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.35 +0.06 (4.65%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/8/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.36 |
Next Year | -0.26 |
EPS (TTM) | -0.41 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.92M | 5.02M | 18.25M | 22.01M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.92M | 5.02M | 18.25M | 22.01M |
Low Estimate | 4.92M | 5.02M | 18.25M | 22.01M |
Year ago Sales | 4.15M | 4.26M | 15.52M | 18.25M |
Year over Year Growth Est. | 18.55% | 17.84% | 17.58% | 20.60% |
Earnings Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.07 | -0.36 | -0.26 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.10 | -0.07 | -0.36 | -0.26 |
High Estimate | -0.10 | -0.07 | -0.36 | -0.26 |
Low Estimate | -0.10 | -0.07 | -0.36 | -0.26 |
Year ago EPS | -0.15 | -0.11 | -0.81 | -0.36 |
Year over Year Growth Est. | 33.33% | 36.36% | 55.56% | 27.78% |
Agreement - Estimate Revisions
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.07 | -0.36 | -0.26 |
7 Days Ago | -0.10 | -0.07 | -0.36 | -0.26 |
30 Days Ago | -0.10 | -0.07 | -0.36 | -0.26 |
60 Days Ago | -0.06 | -0.05 | -0.32 | -0.20 |
90 Days Ago | -0.06 | -0.05 | -0.32 | -0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.07 | -0.36 | -0.26 |
Zacks Consensus Estimate | -0.10 | -0.07 | -0.36 | -0.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Quarter Ending (4/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.07 | -0.11 | -0.15 | NA |
Estimate | -0.08 | -0.09 | -0.17 | -0.12 | NA |
Difference | 0.00 | 0.02 | 0.06 | -0.03 | 0.01 |
Surprise | 0.00% | 22.22% | 35.29% | -25.00% | 8.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more